Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension

Abstract Background This was a phase 3, randomized, double-blind, placebo-controlled study. Methods Adult Korean patients with essential hypertension and a baseline mean sitting clinic systolic blood pressure (scSBP) ≥150 and ≤180 mmHg were randomized to 6-week treatment with placebo (n = 65), azils...

書目詳細資料
發表在:	Clinical Hypertension
Main Authors:	Attila Juhasz, Jingtao Wu, Michie Hisada, Tomoka Tsukada, Myung Ho Jeong
格式:	Article
語言:	英语
出版:	XMLink 2018-02-01
主題:	Hypertension Azilsartan medoxomil Angiotensin II receptor antagonist Blood pressure Korea
在線閱讀:	http://link.springer.com/article/10.1186/s40885-018-0086-4

相似書籍

Looking for an optimal antihypertensive combination. Focus on azilsartan medoxomil/chlorthalidone
由: M. D. Smirnova, et al.
出版: (2025-01-01)

MODERN OPPORTUNITIES FOR ANTIHYPERTENSION THERAPY: THE PLACE OF AZILSARTAN MEDOXOMIL
由: V. V. Skibitsky, et al.
出版: (2017-12-01)

Efficacy and safety of azilsartan medoxomil in the treatment of hypertension: a systematic review and meta-analysis
由: Ling Zhu, et al.
出版: (2024-07-01)

Comparative analysis of antihypertensive effects of chlorthalidone and indapamide-retard in combination with azilsartan medoxomil in patients with arterial hypertension
由: Zh. D. Kobalava, et al.
出版: (2019-07-01)

Central Composite Design Implemented Azilsartan Medoxomil Loaded Nanoemulsion to Improve Its Aqueous Solubility and Intestinal Permeability: In Vitro and Ex Vivo Evaluation
由: Girish Kumar, et al.
出版: (2022-10-01)

AZILSARTAN AS A POTENT ANTIHYPERTENSIVE DRUG WITH POSSIBLE PLEIOTROPIC CARDIOMETABOLIC EFFECTS: A REVIEW STUDY.
由: Georgiopoulos Georgios, et al.
出版: (2016-08-01)

Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes
由: A. M. Kochergina, et al.
出版: (2023-11-01)

EFFICACY OF AZILSARTAN MEDOXOMIL ON THE DAILY PROFILE OF PERIPHERAL AND CENTRAL ARTERIAL PRESSURE AND ARTERIAL STIFFNESS IN HYPERTENSIVES WITH TYPE 2 DIABETES
由: E. A. Troitskaya, et al.
出版: (2017-02-01)

EFFECT OF ANGIOTENSIN RECEPTOR BLOCKADE ON ENDOTHELIAL FUNCTION: FOCUS ON OLMESARTAN MEDOXOMIL
由: C. Ferrario
出版: (2010-12-01)

Azilsartan medoxomil for improving insulin resistance and adipokine levels in hypertension in comparison with angiotensin-converting enzyme inhibitors
由: S. V. Nedogoda, et al.
出版: (2020-08-01)

Possible combined effect of perindopril and Azilsartan in an experimental model of dementia in rats
由: Yahya M. Alzahrani, et al.
出版: (2020-05-01)

Comparative Efficacy of Single Pill Combinations of Azilsartan Medoxomil/Chlorthalidone and Losartan/Hydrochlorothiazide in Patients with Hypertension and Heart Failure with Preserved Ejection Fraction
由: Zh. D. Kobalava, et al.
出版: (2022-05-01)

EVALUATION OF ANTIHYPERTENSIVE THERAPY WITH THE COMBINATION OF OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
由: Steven G. Chrysant, et al.
出版: (2011-06-01)

Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review
由: Vadim D. Zakiev, et al.
出版: (2023-11-01)

Azilsartan inhibits inflammation-triggered bone resorption and osteoclastogenesis in vivo via suppression of TNF-α expression in macrophages
由: Ziqiu Fan, et al.
出版: (2023-09-01)

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
由: R. P. Mason
出版: (2012-06-01)

UPLC–MS/MS for the determination of azilsartan in beagle dog plasma and its application in a pharmacokinetics study
由: Cheng Gong, et al.
出版: (2015-06-01)

Stronger Effect of Azilsartan on Reduction of Proteinuria Compared to Candesartan in Patients with CKD: A Randomized Crossover Trial
由: Takaichi Suehiro, et al.
出版: (2021-03-01)

Effects of two different angiotensin receptor blockers on blood glucose level and HbA1c in type-2 diabetes mellitus patients with hypertension
由: Shafat Iqbal Bhati, et al.
出版: (2023-10-01)

Optimization, characterization and in vitro/vivo evaluation of azilsartan nanocrystals
由: Jingjing Ma, et al.
出版: (2017-07-01)

Is the newest angiotensin‐receptor blocker azilsartan medoxomil more efficacious in lowering blood pressure than the older ones? A systematic review and network meta‐analysis
由: Ji‐Guang Wang, et al.
出版: (2021-05-01)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
由: Hyun Woo Lee, et al.
出版: (2021-03-01)

Olmesartan medoxomil-loaded mixed micelles: Preparation, characterization and in-vitro evaluation
由: Mohamed A. El-Gendy, et al.
出版: (2017-12-01)

A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension
由: Hiromi Rakugi, et al.
出版: (2018-05-01)

Isolation and structural elucidation of novel degradant during degradation study of Azilsartan kamedoxomil
由: Anil Kumar Guduri, et al.
出版: (2024-12-01)

Unique mode of binding between angiotensin II type 1 receptor and its blockers
由: Yoshino Matsuo, et al.
出版: (2019-11-01)

The use of angiotensin receptor blockers in dementia prevention
由: Jordana de Araujo Müller, et al.
出版: (2023-09-01)

Synthesis of Two Novel Azilsartan Cocrystals: Preparation, Physicochemical Characterization and Solubility Studies
由: Lei Gao, et al.
出版: (2020-08-01)

The Possible Hepatoprotective Effects of Azilsartan against Carbon Tetrachloride CCl4 - Induced Liver Fibrosis in Male Rats in Comparison with Silymarin: ''in vivo Study''
由: Mohammed Jasim Mohammed, et al.
出版: (2025-09-01)

Host–Guest Interaction Study of Olmesartan Medoxomil with β-Cyclodextrin Derivatives
由: Minodora Andor, et al.
出版: (2024-05-01)

Gastroprotective Effect of Azilsartan Through Ameliorating Oxidative Stress, Inflammation, and Restoring Hydroxyproline, and Gastrin Levels in Ethanol-Induced Gastric Ulcer
由: Hama Amin RR, et al.
出版: (2022-05-01)

ANTIHYPERTENSIVE EFFICACY OF OLMESARTAN MEDOXOMIL, A NEW ANGIOTENSIN II RECEPTOR ANTAGONIST, AS ASSESSED BY AMBULATORY BLOOD PRESSURE MEASUREMENTS
由: J. M. Neutel, et al.
出版: (2011-04-01)

Intraoperative angioedema induced by angiotensin II receptor blocker: a case report
由: Ala”a Alhowary, et al.
出版: (2018-09-01)

Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19
由: Azadeh Khalili, et al.
出版: (2021-07-01)

Dipping pattern of nocturnal blood pressure in hypertensive patients treated with azilsartan
由: P. L. N. Kapardhi, et al.
出版: (2020-01-01)

Interaction and Compatibility Studies in the Development of Olmesartan Medoxomil and Hydrochlorothiazide Formulations under a Real Manufacturing Process
由: Mac Arturo Murillo-Fernández, et al.
出版: (2022-02-01)

Host–Guest Complexation of Olmesartan Medoxomil by Heptakis(2,6-di-O-methyl)-β-cyclodextrin: Compatibility Study with Excipients
由: Dana Emilia Man, et al.
出版: (2024-12-01)

Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation
由: Rania Moataz El-Dahmy, et al.
出版: (2023-03-01)

Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)
由: Park JS, et al.
出版: (2016-08-01)

Association Between Angiotensin II Receptor Blockers and the Risk of Lung Cancer Among Patients With Hypertension From the Korean National Health Insurance Service-National Health Screening Cohort
由: Sungji Moon, et al.
出版: (2020-11-01)